A team of Canadian researchers has developed a new way to detect melanoma before the cancer becomes visible on the skin, potentially giving doctors a critical head start against one of the deadliest forms of skin cancer.

The experimental platform, called SMEAR-ULM, identifies tiny heat changes produced by early-stage tumors using a combination of microneedles, nanoparticles, and ultrafast imaging. Researchers say the system detected micro-melanomas just four days after they formed in laboratory models, far earlier than conventional thermal imaging systems can manage.

Melanoma survival rates improve dramatically when doctors catch the disease early. The problem is that the smallest tumors often blend into normal skin during routine exams.

Current diagnosis still depends heavily on visual checks followed by biopsies. That process can miss aggressive lesions in their earliest stages or lead to unnecessary procedures for harmless spots. The Canadian researchers focused on heat, something tumors naturally produce.

Cancer cells burn energy faster than healthy tissue. That metabolic activity creates subtle temperature differences across the skin surface. Scientists have known about the effect for years, but existing thermal cameras lack the precision needed to turn it into a reliable diagnostic tool.

SMEAR-ULM changes that equation.

“Our goal is to provide a minimally invasive tool to detect very small, but still aggressive melanomas,” said Jinyang Liang, who specializes in ultrafast imaging and biophotonics. Liang said many dangerous melanomas remain too small for visual screening, leaving patients exposed to cancers that continue growing unnoticed.

The system works through a small patch of painless microneedles placed on the skin. Those needles deposit rare-earth nanoparticles just beneath the surface, creating what researchers describe as a temporary “intelligent tattoo.”

The particles act like microscopic temperature sensors. When researchers shine near-infrared light onto the skin, the nanoparticles emit visible light. The duration of that glow changes depending on local temperature. SMEAR-ULM then captures the response in a single ultrafast snapshot and converts it into a detailed thermal map.

Traditional microneedle sensing systems often require repeated scans, making them difficult to use in living tissue. Conventional infrared imaging also struggles with blurry resolution and image noise. Most thermal systems only detect tumors larger than five millimeters, large enough for doctors to already notice during an exam.

The researchers say SMEAR-ULM pushes well beyond that limit. “We capture all the necessary information for an instantaneous temperature map in a single shot,” said Yingming Lai. He said the method remains stable even under complex in vivo conditions.

Beyond melanoma detection

The study used mouse models engineered with genetic mutations similar to human melanoma. According to the researchers, the results suggest the platform could eventually move toward clinical testing in people. “Even though this study was conducted in mice, this animal model replicates the genetic changes observed in human melanomas,” said Sylvain Meloche.

The team believes the technology could eventually expand beyond cancer detection. Future versions may monitor other biological signals, including pH levels and ion concentrations, opening the door to broader biomedical imaging applications. For now, the breakthrough centers on one goal: spotting deadly skin cancer before the human eye ever can.